TY - JOUR
T1 - Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study
AU - Sacco, Emilio
AU - Bientinesi, Riccardo
AU - Gandi, Carlo
AU - Palermo, Giuseppe
AU - Pierconti, Francesco
AU - Bassi, Pierfrancesco
PY - 2018
Y1 - 2018
N2 - Aims: To objectively assess and enhance the appropriateness of continence products provision to sufferers from urinary incontinence (UI) managed with containment strategies. Methods: Incontinent patients of five Italian continence care services were included in this industry-supported study from 01/2012 to 03/2016. All patients/carers have been invited to perform a 48-h home-based pad test and to fill in a diary. The primary outcome was the product appropriateness defined as the use of a pad with maximum absorbent capacity (MAC) from 30% to 50% higher than the individually measured urine load. Pads provision was corrected accordingly. Meaningful factors affecting products appropriateness and patient's satisfaction with the new products were also assessed. Results: The study included 14 493 subjects (mean age 78 years; 26% males, 74% females) using overall during the study days 98 362 pads. Sixty percent of the products were found to be not appropriate. In most of cases, (75%) products were inappropriate because too large. Age and pad weight gain, followed by gender, body weight, waist circumference, level of autonomy and mobility, pad wearing time, skin health status, and health district were independently associated to the propensity to inappropriateness. After correction of products prescription, a significant reduction (â31%) of the use of largest products was observed. At 6 months evaluation, 88% of evaluable participants were satisfied with the new prescription. Conclusions: Most of patients are provided with not appropriate containment products. The use of the 48-h pad test allows improving on an individual basis the appropriateness of products provision.
AB - Aims: To objectively assess and enhance the appropriateness of continence products provision to sufferers from urinary incontinence (UI) managed with containment strategies. Methods: Incontinent patients of five Italian continence care services were included in this industry-supported study from 01/2012 to 03/2016. All patients/carers have been invited to perform a 48-h home-based pad test and to fill in a diary. The primary outcome was the product appropriateness defined as the use of a pad with maximum absorbent capacity (MAC) from 30% to 50% higher than the individually measured urine load. Pads provision was corrected accordingly. Meaningful factors affecting products appropriateness and patient's satisfaction with the new products were also assessed. Results: The study included 14 493 subjects (mean age 78 years; 26% males, 74% females) using overall during the study days 98 362 pads. Sixty percent of the products were found to be not appropriate. In most of cases, (75%) products were inappropriate because too large. Age and pad weight gain, followed by gender, body weight, waist circumference, level of autonomy and mobility, pad wearing time, skin health status, and health district were independently associated to the propensity to inappropriateness. After correction of products prescription, a significant reduction (â31%) of the use of largest products was observed. At 6 months evaluation, 88% of evaluable participants were satisfied with the new prescription. Conclusions: Most of patients are provided with not appropriate containment products. The use of the 48-h pad test allows improving on an individual basis the appropriateness of products provision.
KW - Neurology (clinical)
KW - Urology
KW - continence products
KW - pad test
KW - pads provision
KW - urinary incontinence
KW - Neurology (clinical)
KW - Urology
KW - continence products
KW - pad test
KW - pads provision
KW - urinary incontinence
UR - http://hdl.handle.net/10807/116182
UR - http://www.interscience.wiley.com/jpages/0733-2467
U2 - 10.1002/nau.23335
DO - 10.1002/nau.23335
M3 - Article
SN - 0733-2467
VL - 37
SP - 485
EP - 495
JO - Neurourology and Urodynamics
JF - Neurourology and Urodynamics
ER -